top of page

Multiomics Revolution in Cancer Care: How Mass Spectrometry-Based Proteomics and Metabolomics Are Advancing Precision Oncology


Challenges of multiomics in personalized medicine: Dual panel visualization showing (A) proteomics challenges including untargeted vs targeted analysis and quantification requirements with protein structure background, and (B) metabolomics challenges including reference material limitations, diverse physicochemical properties, dynamic changes, and unpredictable fragmentation patterns illustrated with molecular structure


Dalton Bioanalytics logo

California NanoSystems Institute

570 Westwood Plaza
Bldg 114, Rm 6350H, Mail 722710
Los Angeles, California 90095‐7227

Copyright © 2025

Dalton Bioanalytics Inc.

Subscribe to Our Newsletter

Thanks for subscribe!

bottom of page